Loxam Teri 4
4 · Vaxcyte, Inc. · Filed Jan 17, 2025
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Loxam Teri
Director
Transactions
- Sale
Common Stock
2025-01-15$80.46/sh−146$11,747→ 13,279 total - Sale
Common Stock
2025-01-15$82.89/sh−1,136$94,168→ 11,928 total - Sale
Common Stock
2025-01-15$85.29/sh−1,043$88,961→ 9,683 total - Sale
Common Stock
2025-01-15$88.54/sh−529$46,836→ 7,175 total - Sale
Common Stock
2025-01-15$86.26/sh−966$83,324→ 8,717 total - Sale
Common Stock
2025-01-15$83.93/sh−1,202$100,885→ 10,726 total - Exercise/Conversion
Stock Option (right to buy)
2025-01-15−6,250→ 6,250 totalExercise: $22.70Exp: 2032-05-31→ Common Stock (6,250 underlying) - Exercise/Conversion
Common Stock
2025-01-15$22.70/sh+6,250$141,875→ 13,425 total - Sale
Common Stock
2025-01-15$81.53/sh−215$17,530→ 13,064 total - Sale
Common Stock
2025-01-15$87.38/sh−1,013$88,513→ 7,704 total
Footnotes (10)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024.
- [F10]Option is fully vested and exercisable.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $80.32 to $80.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The price reported is a weighted-average price. The shares were sold at prices ranging from $81.36 to $81.735. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The price reported is a weighted-average price. The shares were sold at prices ranging from $82.455 to $83.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]The price reported is a weighted-average price. The shares were sold at prices ranging from $83.51 to $84.37. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F6]The price reported is a weighted-average price. The shares were sold at prices ranging from $84.83 to $85.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F7]The price reported is a weighted-average price. The shares were sold at prices ranging from $85.89 to $86.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F8]The price reported is a weighted-average price. The shares were sold at prices ranging from $86.89 to $87.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F9]The price reported is a weighted-average price. The shares were sold at prices ranging from $87.915 to $88.91. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.